DE69434875D1 - BMP-11 Zusammenstellungen - Google Patents
BMP-11 ZusammenstellungenInfo
- Publication number
- DE69434875D1 DE69434875D1 DE69434875T DE69434875T DE69434875D1 DE 69434875 D1 DE69434875 D1 DE 69434875D1 DE 69434875 T DE69434875 T DE 69434875T DE 69434875 T DE69434875 T DE 69434875T DE 69434875 D1 DE69434875 D1 DE 69434875D1
- Authority
- DE
- Germany
- Prior art keywords
- proteins
- bmp
- useful
- disclosed
- compilations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0619—Neurons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6146493A | 1993-05-12 | 1993-05-12 | |
US61464 | 1993-05-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69434875D1 true DE69434875D1 (de) | 2006-12-07 |
DE69434875T2 DE69434875T2 (de) | 2007-09-06 |
Family
ID=22035966
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69434875T Expired - Lifetime DE69434875T2 (de) | 1993-05-12 | 1994-05-12 | BMP-11 Zusammenstellungen |
DE69433530T Expired - Lifetime DE69433530T2 (de) | 1993-05-12 | 1994-05-12 | Bmp-11 zusammensetzungen |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69433530T Expired - Lifetime DE69433530T2 (de) | 1993-05-12 | 1994-05-12 | Bmp-11 zusammensetzungen |
Country Status (17)
Country | Link |
---|---|
US (7) | US5639638A (de) |
EP (4) | EP1770161A3 (de) |
JP (2) | JP3681069B2 (de) |
KR (1) | KR100227406B1 (de) |
AT (2) | ATE343635T1 (de) |
AU (1) | AU678582B2 (de) |
BR (1) | BR9406715A (de) |
CA (1) | CA2161808C (de) |
DE (2) | DE69434875T2 (de) |
DK (2) | DK0698094T3 (de) |
ES (2) | ES2274157T3 (de) |
FI (1) | FI119696B (de) |
HK (1) | HK1060898A1 (de) |
NO (1) | NO320119B1 (de) |
OA (1) | OA10191A (de) |
PT (2) | PT1378572E (de) |
WO (1) | WO1994026892A1 (de) |
Families Citing this family (134)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE20004692U1 (de) | 2000-03-14 | 2001-07-26 | Sofamor Danek Gmbh | Wirbelimplantat zum Einschrauben in einen Wirbelzwischenraum |
US6150328A (en) * | 1986-07-01 | 2000-11-21 | Genetics Institute, Inc. | BMP products |
US20080070842A1 (en) * | 1991-11-04 | 2008-03-20 | David Israel | Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
DE69233022T2 (de) * | 1991-11-04 | 2004-02-12 | Genetics Institute, LLC, Cambridge | Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung |
US7393682B1 (en) * | 1993-03-19 | 2008-07-01 | The Johns Hopkins University School Of Medicine | Polynucleotides encoding promyostatin polypeptides |
US6465239B1 (en) * | 1993-03-19 | 2002-10-15 | The John Hopkins University School Of Medicine | Growth differentiation factor-8 nucleic acid and polypeptides from aquatic species and non-human transgenic aquatic species |
US20030074680A1 (en) * | 1993-03-19 | 2003-04-17 | Johns Hopkins University School Of Medicine | Growth differentiation factor-8 |
JP3681069B2 (ja) * | 1993-05-12 | 2005-08-10 | ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー | Bmp−11組成物 |
US6291206B1 (en) * | 1993-09-17 | 2001-09-18 | Genetics Institute, Inc. | BMP receptor proteins |
CA2176942C (en) * | 1993-12-07 | 2011-11-01 | Anthony J. Celeste | Bmp-12, bmp-13 and tendon-inducing compositions thereof |
US5942496A (en) | 1994-02-18 | 1999-08-24 | The Regent Of The University Of Michigan | Methods and compositions for multiple gene transfer into bone cells |
US6551618B2 (en) | 1994-03-15 | 2003-04-22 | University Of Birmingham | Compositions and methods for delivery of agents for neuronal regeneration and survival |
US7332575B2 (en) * | 1994-03-18 | 2008-02-19 | The Johns Hopkins University School Of Medicine | Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
US5906827A (en) † | 1994-06-03 | 1999-05-25 | Creative Biomolecules, Inc. | Matrix for the manufacture of autogenous replacement body parts |
US6008434A (en) | 1994-07-08 | 1999-12-28 | Johns Hopkins University School Of Medicine | Growth differentiation factor-11 transgenic mice |
US20030167492A1 (en) | 1994-07-08 | 2003-09-04 | Johns Hopkins University School Of Medicine | Transgenic non-human animals expressing a gdf-11 dominant negative polypeptide, and methods of making and using same |
CA2194660C (en) * | 1994-07-08 | 2009-09-29 | Se-Jin Lee | Growth differentiation factor-11 |
US5846770A (en) * | 1994-11-22 | 1998-12-08 | Genetics Institute, Inc. | DNA molecules encoding human chordin |
US5645084A (en) * | 1995-06-07 | 1997-07-08 | Danek Medical, Inc. | Method for spinal fusion without decortication |
US5635372A (en) * | 1995-05-18 | 1997-06-03 | Genetics Institute, Inc. | BMP-15 compositions |
EP2289536A1 (de) | 1995-06-05 | 2011-03-02 | Genetics Institute, LLC | Verwendung von Knochenmorphogeneseproteinen zur Heilung und Reparatur von Bindegewebebefestigung |
US5902785A (en) * | 1995-06-06 | 1999-05-11 | Genetics Institute, Inc. | Cartilage induction by bone morphogenetic proteins |
US5700774A (en) * | 1996-03-26 | 1997-12-23 | Genetics Institute, Inc. | Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same |
US5965403A (en) | 1996-09-18 | 1999-10-12 | Genetics Institute, Inc. | Nucleic acids encoding bone morphogenic protein-16 (BMP-16) |
US6037519A (en) * | 1997-10-20 | 2000-03-14 | Sdgi Holdings, Inc. | Ceramic fusion implants and compositions |
CA2283461A1 (en) * | 1997-03-14 | 1998-09-17 | Uab Research Foundation | Adenoviral vectors with modified tropism |
US7041641B2 (en) | 1997-03-20 | 2006-05-09 | Stryker Corporation | Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects |
US20010016646A1 (en) | 1998-03-20 | 2001-08-23 | David C. Rueger | Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects |
CA2291514C (en) | 1997-05-30 | 2011-07-12 | Creative Biomolecules, Inc. | Methods for evaluating tissue morphogenesis and activity |
US5972368A (en) | 1997-06-11 | 1999-10-26 | Sdgi Holdings, Inc. | Bone graft composites and spacers |
US7923250B2 (en) | 1997-07-30 | 2011-04-12 | Warsaw Orthopedic, Inc. | Methods of expressing LIM mineralization protein in non-osseous cells |
WO1999006563A1 (en) | 1997-07-30 | 1999-02-11 | Emory University | Novel bone mineralization proteins, dna, vectors, expression systems |
US6696260B1 (en) * | 1997-08-01 | 2004-02-24 | The Johns Hopkins University School Of Medicine | Methods to identify growth differentiation factor (GDF) binding proteins |
US6891082B2 (en) * | 1997-08-01 | 2005-05-10 | The Johns Hopkins University School Of Medicine | Transgenic non-human animals expressing a truncated activintype II receptor |
AU8666398A (en) * | 1997-08-01 | 1999-02-22 | Johns Hopkins University School Of Medicine, The | Methods to identify growth differentiation factor (gdf) receptors |
US20020052026A1 (en) | 1997-10-08 | 2002-05-02 | Steven M. Vicik | Methods of refolding proteins |
US6511509B1 (en) | 1997-10-20 | 2003-01-28 | Lifenet | Textured bone allograft, method of making and using same |
AU1276399A (en) * | 1997-11-07 | 1999-05-31 | Genetics Institute Inc. | Neuronal uses of bmp-11 |
US6027917A (en) | 1997-12-10 | 2000-02-22 | Genetics Institute, Inc. | Bone morphogenetic protein (BMP)-17 and BMP-18 compositions |
US20030036629A1 (en) * | 1997-12-12 | 2003-02-20 | Barry Foster | Novel tgf-beta protein purification methods |
US6004937A (en) * | 1998-03-09 | 1999-12-21 | Genetics Institute, Inc. | Use of follistatin to modulate growth and differentiation factor 8 [GDF-8] and bone morphogenic protein 11 [BMP-11] |
US7147839B2 (en) | 1998-05-29 | 2006-12-12 | Curis, Inc. | Methods for evaluating tissue morphogenesis and activity |
WO2000006716A1 (en) * | 1998-07-28 | 2000-02-10 | The Johns Hopkins University School Of Medicine | Growth differentiation factor-11 |
AU5341999A (en) | 1998-08-06 | 2000-02-28 | Sdgi Holdings, Inc. | Composited intervertebral bone spacers |
US6849255B2 (en) * | 1998-08-18 | 2005-02-01 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Methods and compositions for enhancing cartilage repair |
US6727224B1 (en) * | 1999-02-01 | 2004-04-27 | Genetics Institute, Llc. | Methods and compositions for healing and repair of articular cartilage |
EP1181041A2 (de) * | 1999-04-30 | 2002-02-27 | Curis, Inc. | Morphogen-induzierte verbesserung der fertilität |
DK1244388T3 (da) | 1999-12-06 | 2007-05-14 | Warsaw Orthopedic Inc | Indretning til behandling af mellemhvirvelskiver |
US20030082233A1 (en) * | 2000-12-01 | 2003-05-01 | Lyons Karen M. | Method and composition for modulating bone growth |
WO2002056800A2 (en) | 2000-12-08 | 2002-07-25 | Osteotech, Inc. | Implant for orthopedic applications |
US6752831B2 (en) | 2000-12-08 | 2004-06-22 | Osteotech, Inc. | Biocompatible osteogenic band for repair of spinal disorders |
US7141392B2 (en) | 2001-01-09 | 2006-11-28 | Queen Mary And Westfield College | Latent fusion protein |
US6942853B2 (en) | 2001-01-09 | 2005-09-13 | Queen Mary And Westfield College | Latent fusion protein |
EP1790726B1 (de) * | 2001-02-08 | 2013-07-03 | Wyeth LLC | Modifizierte und stabilisierte GDF-Propeptide und ihre Verwendung |
TWI329129B (en) | 2001-02-08 | 2010-08-21 | Wyeth Corp | Modified and stabilized gdf propeptides and uses thereof |
KR100420798B1 (ko) * | 2001-02-10 | 2004-03-02 | (주)알에이싸이언스 | 펩타이드 벡터 |
DE60226321T2 (de) * | 2001-06-01 | 2009-07-09 | Wyeth | Zusammensetzungen für die systemische verabreichung von sequenzen, die für knochenmorphogenese-proteinen kodieren |
TWI267378B (en) | 2001-06-08 | 2006-12-01 | Wyeth Corp | Calcium phosphate delivery vehicles for osteoinductive proteins |
US7320789B2 (en) | 2001-09-26 | 2008-01-22 | Wyeth | Antibody inhibitors of GDF-8 and uses thereof |
US6798160B2 (en) * | 2001-11-02 | 2004-09-28 | Honda Giken Kogyo Kabushiki Kaisha | Electric working machine |
CN1301757C (zh) * | 2001-11-27 | 2007-02-28 | 多喜兰株式会社 | 植入物材料及其生产方法 |
CH695985A5 (de) * | 2002-01-21 | 2006-11-15 | Straumann Holding Ag | Oberflächenmodifizierte Implantate. |
CA2476887A1 (en) | 2002-02-21 | 2003-09-04 | Wyeth | Gasp1:a follistatin domain containing protein |
PL374966A1 (en) * | 2002-02-21 | 2005-11-14 | Wyeth | Follistatin domain containing proteins |
TWI282283B (en) * | 2002-05-17 | 2007-06-11 | Wyeth Corp | Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
EP1542711A4 (de) | 2002-08-13 | 2009-07-01 | Wyeth Corp | Peptide als solubilisierende hilfsstoffe zur umwandlung von wachstumsfaktor-proteinen |
ES2344734T3 (es) * | 2002-09-16 | 2010-09-06 | Johns Hopkins University | Activacion de miostatina por metaloproteasa, y metodos para modular la actividad de miostatina. |
AR047392A1 (es) | 2002-10-22 | 2006-01-18 | Wyeth Corp | Neutralizacion de anticuerpos contra gdf 8 y su uso para tales fines |
US20040223966A1 (en) * | 2002-10-25 | 2004-11-11 | Wolfman Neil M. | ActRIIB fusion polypeptides and uses therefor |
EP1635870A2 (de) * | 2003-06-02 | 2006-03-22 | Wyeth | Verwendung von myostatin (gdf8) inhibitoren in kombination mit kortikosteroiden zur behandlung neuromuskulärer erkrankungen |
ES2282904T3 (es) * | 2003-09-12 | 2007-10-16 | Wyeth | Barras solidas de fosfato calcico inyectables para el suministro de proteinas osteogenicas. |
PT1737734E (pt) | 2004-03-10 | 2010-11-11 | Scil Technology Gmbh | Implantes revestidos, seu fabrico e utilização |
US7575751B2 (en) | 2004-04-27 | 2009-08-18 | Research Development Foundation | Activin-A mutants |
EP2298335B1 (de) | 2004-05-25 | 2014-09-03 | Stryker Corporation | Verwendung von OP-1 zur Behandlung von Knorpeldefekten |
US7749268B2 (en) | 2004-05-26 | 2010-07-06 | Warsaw Orthopedic, Inc. | Methods for treating the spine |
WO2006020884A2 (en) * | 2004-08-12 | 2006-02-23 | Wyeth | Combination therapy for diabetes, obesity, and cardiovascular diseases using gdf-8 inhibitors |
US7473678B2 (en) | 2004-10-14 | 2009-01-06 | Biomimetic Therapeutics, Inc. | Platelet-derived growth factor compositions and methods of use thereof |
US20060166251A1 (en) * | 2005-01-26 | 2006-07-27 | Archambault Joanne M | Use of sFRPs as markers of BMP activity |
CN101137906A (zh) * | 2005-03-23 | 2008-03-05 | 惠氏公司 | 对gdf-8调节剂的免疫应答的检测 |
AU2006230434A1 (en) * | 2005-03-30 | 2006-10-05 | Wyeth | Methods for stimulating hair growth by administering BMPs |
US8506646B2 (en) | 2005-04-29 | 2013-08-13 | Warsaw Orthopedic, Inc. | Multi-purpose medical implant devices |
US20060247790A1 (en) * | 2005-04-30 | 2006-11-02 | Mckay William F | Shaped osteochondral grafts and methods of using same |
CN101277976B (zh) | 2005-10-06 | 2012-04-11 | 伊莱利利公司 | 抗肌抑制素抗体 |
UA92504C2 (en) | 2005-10-12 | 2010-11-10 | Эли Лилли Энд Компани | Anti-myostatin monoclonal antibody |
US8147860B2 (en) | 2005-12-06 | 2012-04-03 | Etex Corporation | Porous calcium phosphate bone material |
EP1991282B1 (de) | 2006-02-09 | 2013-06-19 | BioMimetic Therapeutics, LLC | Zusammensetzungen und verfahren zur behandlung von knochen |
CA2652549A1 (en) | 2006-05-17 | 2007-12-13 | Stryker Corporation | Use of a soluble morphogenic protein complex for treating cartilage defects |
ES2664229T3 (es) | 2006-06-30 | 2018-04-18 | Biomimetic Therapeutics, Llc | Composiciones y métodos de biomatriz-PDGF para el tratamiento de lesiones del manguito rotador |
US9161967B2 (en) | 2006-06-30 | 2015-10-20 | Biomimetic Therapeutics, Llc | Compositions and methods for treating the vertebral column |
US8524265B2 (en) | 2006-08-17 | 2013-09-03 | Warsaw Orthopedic, Inc. | Medical implant sheets useful for tissue regeneration |
CA2661836A1 (en) | 2006-09-05 | 2008-03-13 | Eli Lilly And Company | Anti-myostatin antibodies |
JP2008104401A (ja) * | 2006-10-25 | 2008-05-08 | Kyoto Univ | 精原幹細胞のインビトロ増殖方法 |
AU2007234612B2 (en) | 2006-12-14 | 2013-06-27 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein stabilization formulations |
JP5452230B2 (ja) | 2006-12-21 | 2014-03-26 | ストライカー コーポレイション | 生物学的因子の結晶、高分子ゲルおよび粒子懸濁液を含む持続放出処方物 |
US7678764B2 (en) | 2007-06-29 | 2010-03-16 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein formulations for use at elevated temperatures |
CN101801405A (zh) | 2007-08-07 | 2010-08-11 | 先进科技及再生医学有限责任公司 | 包含于酸性水溶液中的gdf-5的蛋白质配方 |
EP2268302B1 (de) | 2008-02-13 | 2014-04-09 | Keith Hruska | Bmp-7 zur behandlung von neointimaler hyperplasie |
EP2276458A1 (de) | 2008-04-14 | 2011-01-26 | Advanced Technologies and Regenerative Medicine, LLC | Flüssige gepufferte gdf-5-formulierungen |
CN102231992B (zh) | 2008-09-09 | 2015-05-20 | 生物模拟治疗公司 | 用于治疗肌腱和韧带损伤的血小板衍生生长因子的组合物和方法 |
JP5819733B2 (ja) | 2009-02-12 | 2015-11-24 | ストライカー コーポレイションStryker Corporation | 障害および疾患に対する全身治療のためのTGF−βスーパーファミリーメンバー含有タンパク質の末梢投与 |
EP2396026A2 (de) | 2009-02-12 | 2011-12-21 | Stryker Corporation | Zusammensetzungen und verfahren für die minimal invasive systemische abgabe von proteinen einschliesslich mitglieder der tgf-superfamilie |
WO2010110974A1 (en) | 2009-03-24 | 2010-09-30 | Stryker Corporation | Methods and compositions for tissue engineering |
US8609127B2 (en) | 2009-04-03 | 2013-12-17 | Warsaw Orthopedic, Inc. | Medical implant with bioactive material and method of making the medical implant |
US20110002897A1 (en) | 2009-06-11 | 2011-01-06 | Burnham Institute For Medical Research | Directed differentiation of stem cells |
US9399086B2 (en) | 2009-07-24 | 2016-07-26 | Warsaw Orthopedic, Inc | Implantable medical devices |
US20110224138A1 (en) | 2009-09-09 | 2011-09-15 | Julie Krop | Methods for treating pain induced by injuries and diseases of an articular joint |
WO2011035094A1 (en) | 2009-09-17 | 2011-03-24 | Stryker Corporation | Buffers for controlling the ph of bone morphogenetic proteins |
JP2013514811A (ja) | 2009-12-22 | 2013-05-02 | ストライカー コーポレイション | 免疫原性が抑制されたbmp−7変異体 |
MX2012009687A (es) | 2010-02-22 | 2012-11-29 | Biomimetic Therapeutics Inc | Metodos y composiciones de factor de crecimiento derivado de plaquetas y métodos para el tratamiento de tendinopatías. |
WO2011139594A2 (en) | 2010-04-27 | 2011-11-10 | Medtronic, Inc. | Artificial bursa for intra-articular drug delivery |
SG187589A1 (en) | 2010-08-20 | 2013-03-28 | Wyeth Llc | Designer osteogenic proteins |
US9688735B2 (en) | 2010-08-20 | 2017-06-27 | Wyeth Llc | Designer osteogenic proteins |
WO2012177759A1 (en) | 2011-06-20 | 2012-12-27 | Rdc Holdings, Llc | System and method for repairing joints |
US8998925B2 (en) | 2011-06-20 | 2015-04-07 | Rdc Holdings, Llc | Fixation system for orthopedic devices |
EP2828289B1 (de) * | 2012-03-19 | 2020-02-26 | The Brigham and Women's Hospital, Inc. | Wachstumsdifferenzierungsfaktor 11 zur behandlung von altersbedingter kardiovaskulärer erkrankung |
WO2014012101A1 (en) | 2012-07-13 | 2014-01-16 | Trustees Of Tufts College | Silk powder compaction for production of constructs with high mechanical strength and stiffness |
EP2956545A4 (de) * | 2013-02-15 | 2016-07-20 | Joslin Diabetes Ct | Thymusregeneration |
EP2983694B1 (de) * | 2013-04-08 | 2022-06-22 | President and Fellows of Harvard College | Zusammensetzungen zur verjüngung von skelettmuskelstammzellen |
WO2014172692A1 (en) | 2013-04-19 | 2014-10-23 | Theracell, Inc. | Demineralized bone fibers having controlled geometry and shapes and methods thereof |
US20160287667A1 (en) * | 2013-11-08 | 2016-10-06 | President And Fellows Of Harvard College | Methods and compositions for rejuvenating neuromuscular junctions |
WO2015073396A1 (en) | 2013-11-12 | 2015-05-21 | The Brigham And Women's Hospital, Inc. | Growth differentiation factor (gdf) for treatment of diastolic heart failure |
US10610366B2 (en) | 2015-01-29 | 2020-04-07 | Theracell, Inc. | Demineralized bone fiber composition for use in minimally invasive surgery |
KR20170138436A (ko) | 2015-03-17 | 2017-12-15 | 이스티튜토 바이오키미코 이탈리아노 지오바니 로렌치니 에스.피.에이. | 골 형성 단백질 (bpm)의 정제 |
KR20180019646A (ko) | 2015-06-17 | 2018-02-26 | 워쏘우 오르쏘페딕 인코포레이티드 | 옥시스테롤을 포함하는 임플란트 및 사용 방법 |
WO2017075055A1 (en) | 2015-10-26 | 2017-05-04 | President And Fellows Of Harvard College | Reduced and oxidized polysaccharides and methods of use thereof |
EP3399998B1 (de) | 2016-01-06 | 2021-07-21 | President and Fellows of Harvard College | Behandlung mit gdf11 zur verhinderung gewichtszunahme, zur verbesserung der glukosetoleranz und zur verringerung der hepatosteatose |
KR101810385B1 (ko) * | 2016-02-04 | 2017-12-20 | 주식회사 강스템바이오텍 | Gdf11을 포함하는 조성물 및 그의 용도 |
US10688222B2 (en) | 2016-11-21 | 2020-06-23 | Warsaw Orthopedic, Inc. | Lyophilized moldable implants containing an oxysterol |
US10639157B2 (en) | 2017-03-14 | 2020-05-05 | Theracell, Inc. | Demineralized bone fiber composition for use in minimally invasive surgery |
US11464888B2 (en) | 2017-06-12 | 2022-10-11 | Warsaw Orthopedic, Inc. | Moldable formulations containing an oxysterol in an acellular tissue matrix |
KR101893339B1 (ko) * | 2017-09-19 | 2018-08-31 | 주식회사 강스템바이오텍 | Gdf11을 포함하는 조성물 및 그의 용도 |
US11103618B2 (en) | 2018-02-22 | 2021-08-31 | Warsaw Orthopedic, Inc. | Demineralized bone matrix having improved handling characteristics |
CN109097425B (zh) * | 2018-08-28 | 2022-06-07 | 浙江康嘉基因技术有限公司 | 一种多肽及用作流感疫苗免疫佐剂的用途 |
US11498880B2 (en) | 2019-07-26 | 2022-11-15 | Warsaw Orthopedic, Inc. | Calcium phosphate granules and methods of making them |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4419446A (en) | 1980-12-31 | 1983-12-06 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA process utilizing a papilloma virus DNA as a vector |
EP0105014B1 (de) | 1982-09-24 | 1992-05-20 | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce | Wiederherstellung von Gewebe bei Tieren |
US4588684A (en) | 1983-04-26 | 1986-05-13 | Chiron Corporation | a-Factor and its processing signals |
NZ210699A (en) | 1984-01-04 | 1989-06-28 | Int Genetic Eng | Isolation of an osteogenic protein of the p3 immunologically related family |
ZA848495B (en) | 1984-01-31 | 1985-09-25 | Idaho Res Found | Production of polypeptides in insect cells |
CA1341617C (en) | 1984-06-08 | 2011-06-28 | Henry George Burger | Inhibin isolated from ovarian follicular fluid |
JP2540509B2 (ja) | 1984-07-06 | 1996-10-02 | サンド・アクチエンゲゼルシヤフト | リンホカインの生産および精製 |
ATE128715T1 (de) | 1984-07-16 | 1995-10-15 | Celtrix Pharma | Polypeptide induzierende faktoren in knochen und knorpel. |
EP0177343B1 (de) | 1984-10-05 | 1992-07-22 | Genentech, Inc. | DNA, Zellkulturen und Verfahren zur Sekretion von heterologen Proteinen und periplasmische Proteinrückgewinnung |
US4740587A (en) * | 1985-07-18 | 1988-04-26 | The Salk Institute For Biological Studies | Inhibin and method of purifying same |
US4798885A (en) | 1986-02-07 | 1989-01-17 | Genentech, Inc. | Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain |
US5089396A (en) * | 1985-10-03 | 1992-02-18 | Genentech, Inc. | Nucleic acid encoding β chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid |
US5215893A (en) * | 1985-10-03 | 1993-06-01 | Genentech, Inc. | Nucleic acid encoding the ba chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid |
NZ231899A (en) * | 1985-10-03 | 1991-07-26 | Genentech Inc | Human or porcine inhibin peptide compositions and dna encoding them |
US4737578A (en) * | 1986-02-10 | 1988-04-12 | The Salk Institute For Biological Studies | Human inhibin |
ZA874681B (en) | 1986-07-01 | 1988-04-27 | Genetics Inst | Novel osteoinductive factors |
US5108922A (en) | 1986-07-01 | 1992-04-28 | Genetics Institute, Inc. | DNA sequences encoding BMP-1 products |
US5013649A (en) | 1986-07-01 | 1991-05-07 | Genetics Institute, Inc. | DNA sequences encoding osteoinductive products |
IL83003A (en) * | 1986-07-01 | 1995-07-31 | Genetics Inst | Factors that soak bone formation |
US5106748A (en) | 1986-07-01 | 1992-04-21 | Genetics Institute, Inc. | Dna sequences encoding 5 proteins |
US5187076A (en) | 1986-07-01 | 1993-02-16 | Genetics Institute, Inc. | DNA sequences encoding BMP-6 proteins |
US5041538A (en) * | 1987-08-28 | 1991-08-20 | The Salk Institute For Biological Studies | Mammalian follistatin |
US5168150A (en) | 1988-03-17 | 1992-12-01 | Electronique Serge Dassault | Device for the processing of a magnetic-track ticket, especially an air transport ticket |
US5071834A (en) | 1988-09-16 | 1991-12-10 | Genentech, Inc. | Purified activin B composition |
US5166190A (en) * | 1990-01-08 | 1992-11-24 | Genentech, Inc. | Method for increasing fertility in males |
ES2168091T3 (es) | 1990-05-16 | 2002-06-01 | Genetics Inst | Proteinas de induccion osea y cartilaginosa. |
US5168050A (en) * | 1990-05-24 | 1992-12-01 | Genentech, Inc. | Mammalian expression of the bone morphogenetic protein-2b using bmp2a/bmp2b fusion |
WO1992005199A1 (en) * | 1990-09-26 | 1992-04-02 | Genetics Institute, Inc. | Bmp-5 derivatives |
JP3356775B2 (ja) * | 1990-11-30 | 2002-12-16 | セルトリックス ファーマシューティカルズ, インコーポレイテッド | TGF―βとの共同的組合せによる骨修復のための骨形成タンパク質の使用 |
US5208219A (en) * | 1991-02-14 | 1993-05-04 | Celtrix Pharmaceuticals Inc. | Method for inducing bone growth |
CA2102808A1 (en) * | 1991-05-10 | 1992-11-11 | Hanne Bentz | Targeted delivery of bone growth factors |
EP0592562B1 (de) | 1991-06-25 | 1999-01-07 | Genetics Institute, Inc. | Bmp-9 zusammensetzungen |
US5171579A (en) * | 1991-10-11 | 1992-12-15 | Genetics Institute, Inc. | Formulations of blood clot-polymer matrix for delivery of osteogenic proteins |
DE69233022T2 (de) * | 1991-11-04 | 2004-02-12 | Genetics Institute, LLC, Cambridge | Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung |
ES2201059T5 (es) | 1992-07-31 | 2007-11-01 | Curis, Inc. | Regeneracion y reparacion de nervios inducida por morfogenos. |
EP0690873B1 (de) * | 1993-03-19 | 2003-06-11 | The Johns Hopkins University School Of Medicine | Wachstumsfaktor-8 |
CA2161807A1 (en) * | 1993-05-12 | 1994-11-24 | Anthony J. Celeste | Bmp-10 compositions |
JP3681069B2 (ja) * | 1993-05-12 | 2005-08-10 | ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー | Bmp−11組成物 |
KR100329409B1 (ko) * | 1993-08-26 | 2002-03-20 | 브루스 엠. 에이센, 토마스 제이 데스로저 | 인간 골 형태발생 단백질을 사용한 신경 재생법 |
CA2194660C (en) * | 1994-07-08 | 2009-09-29 | Se-Jin Lee | Growth differentiation factor-11 |
US5545616A (en) * | 1994-09-22 | 1996-08-13 | Genentech, Inc. | Method for predicting and/or preventing preterm labor |
ATE493141T1 (de) | 1996-03-22 | 2011-01-15 | Stryker Corp | Verfahren zur verbesserten funktionellen erholung der motorischen koordiination, der sprache oder der sinneswahrnehmung nach trauma oder ischämie des zns |
JP3361278B2 (ja) | 1997-12-26 | 2003-01-07 | シャープ株式会社 | 反射型液晶表示装置とその製造方法、ならびに回路基板の製造方法 |
US6004937A (en) * | 1998-03-09 | 1999-12-21 | Genetics Institute, Inc. | Use of follistatin to modulate growth and differentiation factor 8 [GDF-8] and bone morphogenic protein 11 [BMP-11] |
-
1994
- 1994-05-12 JP JP52569894A patent/JP3681069B2/ja not_active Expired - Fee Related
- 1994-05-12 BR BR9406715A patent/BR9406715A/pt not_active Application Discontinuation
- 1994-05-12 KR KR1019950704836A patent/KR100227406B1/ko not_active IP Right Cessation
- 1994-05-12 AT AT03021107T patent/ATE343635T1/de active
- 1994-05-12 DE DE69434875T patent/DE69434875T2/de not_active Expired - Lifetime
- 1994-05-12 EP EP06022258A patent/EP1770161A3/de not_active Withdrawn
- 1994-05-12 EP EP10181708A patent/EP2272959A1/de not_active Withdrawn
- 1994-05-12 DK DK94917361T patent/DK0698094T3/da active
- 1994-05-12 EP EP03021107A patent/EP1378572B1/de not_active Expired - Lifetime
- 1994-05-12 WO PCT/US1994/005288 patent/WO1994026892A1/en active IP Right Grant
- 1994-05-12 CA CA002161808A patent/CA2161808C/en not_active Expired - Fee Related
- 1994-05-12 PT PT03021107T patent/PT1378572E/pt unknown
- 1994-05-12 AT AT94917361T patent/ATE258984T1/de active
- 1994-05-12 ES ES03021107T patent/ES2274157T3/es not_active Expired - Lifetime
- 1994-05-12 DE DE69433530T patent/DE69433530T2/de not_active Expired - Lifetime
- 1994-05-12 EP EP94917361A patent/EP0698094B1/de not_active Expired - Lifetime
- 1994-05-12 PT PT94917361T patent/PT698094E/pt unknown
- 1994-05-12 DK DK03021107T patent/DK1378572T3/da active
- 1994-05-12 ES ES94917361T patent/ES2213745T3/es not_active Expired - Lifetime
- 1994-05-12 AU AU69105/94A patent/AU678582B2/en not_active Ceased
- 1994-05-20 US US08/247,907 patent/US5639638A/en not_active Expired - Lifetime
-
1995
- 1995-05-30 US US08/452,772 patent/US5700911A/en not_active Expired - Lifetime
- 1995-11-08 NO NO19954492A patent/NO320119B1/no not_active IP Right Cessation
- 1995-11-10 FI FI955419A patent/FI119696B/fi not_active IP Right Cessation
- 1995-11-10 OA OA60735A patent/OA10191A/en unknown
-
1997
- 1997-08-28 US US08/919,850 patent/US6437111B1/en not_active Expired - Fee Related
-
1999
- 1999-10-07 US US09/414,234 patent/US6340668B1/en not_active Expired - Fee Related
-
2001
- 2001-12-20 US US10/029,016 patent/US20030083252A1/en not_active Abandoned
-
2002
- 2002-07-05 US US10/188,886 patent/US7175997B2/en not_active Expired - Fee Related
-
2004
- 2004-05-27 HK HK04103794A patent/HK1060898A1/xx not_active IP Right Cessation
- 2004-08-24 JP JP2004243948A patent/JP2005046155A/ja active Pending
-
2006
- 2006-04-11 US US11/401,228 patent/US20060172391A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69434875D1 (de) | BMP-11 Zusammenstellungen | |
ATE265529T1 (de) | Bmp-10 zusammensetzungen | |
DK0429570T3 (da) | Osteoinducerende præparater | |
DE69821793D1 (de) | Neuronale verwendungen des bmp-11 | |
ATE328896T1 (de) | Faktor viii vom schwein und hybriden | |
EP0787802A3 (de) | ||
DE69528058T2 (de) | Bmp-9 zusammensetzungen | |
ATE388165T1 (de) | Menschliches cnp-gen und vorläuferprotein | |
GR3033698T3 (en) | Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections. | |
DK1431391T3 (da) | RANTES-mutanter og terapeutiske anvendelser heraf | |
EP0723016A3 (de) | Leukocyten-aktivierender Faktor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |